ENDALIS
ENDALIS
ENDALIS has developed END BALL, a non-surgical, temporary intragastric balloon system for the treatment of obesity. The intragastric balloon acts through the filling of the stomach which causes a feeling of satiety and a reduction of food intake. Its duration of use is less than or equal to 6 months and is intended to allow weight loss when a monitored weight loss program has not been sufficient.T he END BALL gatsric balloon is distributed around the world.
Company details
Find locations served, office locations.
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Globally (various continents)
- Year Founded:
- 2007
